tiprankstipranks
Trending News
More News >
Grand Pharmaceutical Group Limited (HK:0512)
:0512
Hong Kong Market

Grand Pharmaceutical Group Limited (0512) Income Statement

Compare
3 Followers

Grand Pharmaceutical Group Limited Income Statement

Last quarter (Q4 2024), Grand Pharmaceutical Group Limited's total revenue was HK$5.60B, an increase of 28.69% from the same quarter last year. In Q4, Grand Pharmaceutical Group Limited's net income was HK$910.43M. See Grand Pharmaceutical Group Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
HK$ 11.64BHK$ 10.53BHK$ 9.56BHK$ 8.60BHK$ 6.35B
Gross Profit
HK$ 6.74BHK$ 6.52BHK$ 5.95BHK$ 5.25BHK$ 4.04B
Operating Expenses
HK$ 4.57BHK$ 3.86BHK$ 3.43BHK$ 3.23BHK$ 2.53B
Depreciation and Amortization
HK$ 503.75MHK$ 392.21MHK$ 394.91MHK$ 339.52MHK$ 287.06M
EBITDA
HK$ 3.39BHK$ 2.97BHK$ 3.09BHK$ 3.10BHK$ 2.41B
Operating Income
HK$ 2.17BHK$ 2.66BHK$ 2.52BHK$ 2.02BHK$ 1.51B
Other Income/Expenses
HK$ 680.33MHK$ -319.20MHK$ 43.05MHK$ 653.39MHK$ 502.33M
Pretax Income
HK$ 2.85BHK$ 2.34BHK$ 2.56BHK$ 2.67BHK$ 2.01B
Net Income
HK$ 2.47BHK$ 1.88BHK$ 2.08BHK$ 2.40BHK$ 1.79B
Per Share Metrics
Basic EPS
HK$ 0.70HK$ 0.54HK$ 0.59HK$ 0.68HK$ 0.52
Diluted EPS
HK$ 0.70HK$ 0.54HK$ 0.59HK$ 0.68HK$ 0.52
Weighted Average Shares Outstanding
3.50B 3.51B 3.54B 3.55B 3.45B
Weighted Average Shares Outstanding (Diluted)
3.50B 3.51B 3.54B 3.55B 3.45B
Currency in HKD

Grand Pharmaceutical Group Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis